Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-25T08:36:55.302Z Has data issue: false hasContentIssue false

WILLINGNESS TO PAY FOR ARTHRITIS SYMPTOM ALLEVIATION

Comparison of Closed-ended Questions With and Without Follow-up

Published online by Cambridge University Press:  04 May 2001

Ulla Slothuus
Affiliation:
University of Southern Denmark
Mette L. Larsen
Affiliation:
University of Southern Denmark
Peter Junker
Affiliation:
University of Southern Denmark

Abstract

Objective: To compare two methods of measuring willingness to pay (WTP): closed-ended questions with and without follow-up.

Methods: A measurement experiment based on dichotomous choice contingent valuation survey data is reported. Marginal WTP estimates for alleviation of rheumatoid arthritis symptoms resulting from treatment with a novel anti-rheumatic agent, cA2 (TNF-α blockade), were calculated. Monte Carlo simulations were undertaken to evaluate the methods with respect to their statistical power.

Results: The estimated marginal WTP values using closed-ended questions with and without follow-up were DKK 637 (US $91) and DKK 1,268 (US $181), respectively. A Wilcoxon's signed-rank test showed that the difference of DKK 631 was significant. Moreover, including a follow-up question increases the precision of the result. Monte Carlo simulations showed that trade-offs between power (i.e., the probability of a correct rejection of a false null hypothesis), efficiency, and size may exist in the two models.

Conclusions: There was a significant difference between the WTP estimates when using closed-ended questions with and without follow-up. When choosing between the models, however, power, efficiency, and size could be used as selection criteria.

Type
Research Article
Copyright
© 2000 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)